Teladoc Health, Inc.

TDOC Healthcare Health Information Services

Teladoc Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, down 1.54% from fiscal 2024.

Revenue
−3.41%
EPS
+47.1%
Free cash flow
+11.8%
Total debt
+0.36%

Quarter to September 2026, against a year earlier

8.78 0.63 −6.70%
Market cap
$1.7B
P/E
0.0×
Fwd P/E
−10.1×
Dividend yield
—
F-score
5/9
Altman Z
−6.66
Beneish M
−3.26
Dividend safety
n/a
Older periods Dec '25 Mar '26 Jun '26 Sep '26
P/E ratio

+8 more quarters

0.00 0.00 0.00 0.00
P/S ratio
0.49 0.39 0.62 0.43
P/FCF ratio
8.98 7.71 17.33 8.36
P/Operating CF
14.06 102.59 23.74 9.91
P/B ratio
0.89 0.73 1.17 0.81
EV/Sales
0.79 0.70 1.11 0.89
EV/EBITDA
10.79 9.38 13.51 10.23
EV/FCF
14.55 13.99 31.09 17.43
Current Ratio
2.77 2.80 0.83 0.87
Net Debt/EBITDA
3.38 7.56 4.02 2.31
Debt/Equity
0.72 0.75 0.76 0.77
Earnings Yield
(16.29%) (17.80%) (11.67%) (14.79%)
Free Cash Flow Yield
11.13% 12.98% 5.77% 11.96%
Free Cash Flow per Share
0.30 (0.15) 0.13 0.42
Book value per Share
7.86 7.46 7.24 7.12
Free Cash Flow
53.42 (26.31) 23.07 75.94
EV/EBIT
0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026